Trial · NCT03200717
Results by group106
Each measurement the trial posted, group by group, in the words and numbers it posted.
81 to 100 of 106
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | Cycle 16 Day 1 | -1.3 | Standard Deviation 11.70 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | Cycle 16 Day 1 | -1.3 | Standard Deviation 11.70 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | Cycle 19 Day 1 | 5.5 | Standard Deviation 10.09 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | Cycle 19 Day 1 | 5.5 | Standard Deviation 10.09 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | Cycle 22 Day 1 | 0.5 | Standard Deviation 9.93 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | Cycle 22 Day 1 | 0.5 | Standard Deviation 9.93 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | Cycle 25 Day 1 | 0.0 | Standard Deviation 9.70 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | Cycle 25 Day 1 | 0.0 | Standard Deviation 9.70 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | Cycle 31 Day 1 | 99.5 | Standard Deviation 0.71 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | Cycle 31 Day 1 | 99.5 | Standard Deviation 0.71 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | Cycle 34 Day 1 | 10.0 | Standard Deviation NA | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | Cycle 34 Day 1 | 10.0 | Standard Deviation NA | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | Cycle 37 Day 1 | 90.0 | Standard Deviation NA | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | Cycle 37 Day 1 | 90.0 | Standard Deviation NA | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 2nd Line | End of Treatment | -1.9 | Standard Deviation 20.84 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | Pazopanib- 3rd Line | End of Treatment | -8.9 | Standard Deviation 19.99 | Score on a scale |
| Change From Baseline in EuroQoL 5-level Instrument Visual Analogue Scale (EQ-5L-5D VAS) Score | All Participants | End of Treatment | -3.6 | Standard Deviation 20.59 | Score on a scale |
| All Collected Deaths | Pazopanib- 2nd Line | On-treatment deaths | 5 | Participants | |
| All Collected Deaths | Pazopanib- 3rd Line | On-treatment deaths | 1 | Participants | |
| All Collected Deaths | All Participants | On-treatment deaths | 6 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03200717/results?page=5